Department of Biological Sciences, Sookmyung Women's University, Seoul 04310, Republic of Korea.
Department of Medicinal Biotechnology, College of Health Sciences, Dong-A University, Busan 49315, Republic of Korea.
Oncol Rep. 2019 Jan;41(1):711-717. doi: 10.3892/or.2018.6850. Epub 2018 Nov 2.
In attempting to identify effective anticancer drugs from natural products that are harmless to humans, we found that the gomisin J from Schisandra chinensis fruit has anticancer activity. Schisandra chinensis fruits are used in traditional herbal medicine and gomisin J is one of their chemical constituents. In the present study, we examined the anticancer activity of gomisin J in MCF7 and MDA-MB-231 breast cancer cell lines and in MCF10A normal cell line, in a time- and concentration-dependent manner. Our data revealed that gomisin J exerted a much stronger cytotoxic effect on MCF7 and MDA-MB-231 cancer cells than on MCF10A normal cells. Gomisin J suppressed the proliferation and decreased the viability of MCF7 and MDA-MB-231 cells at relatively low (<10 µg/ml) and high (>30 µg/ml) concentrations, respectively. Our data also revealed that gomisin J induced necroptosis, a programmed form of necrosis, as well as apoptosis. Notably, gomisin J predominantly induced necroptosis in MCF7 cells that are known to have high resistance to many pro-apoptotic anticancer drugs, while MDA-MB-231 exhibited a much lower level of necroptosis but instead a higher level of apoptosis. This data indicated the possibility that it may be used as a more effective anticancer drug, especially in apoptosis-resistant malignant cancer cells. In an extended study, gomisin J exhibited a strong cytotoxic effect on all tested various types of 13 cancer cell lines, indicating its potential to be used against a wide range of different types of cancer cells.
在试图从对人体无害的天然产物中寻找有效的抗癌药物时,我们发现五味子果实中的戈米辛 J 具有抗癌活性。五味子果实被用于传统草药中,戈米辛 J 是其化学成分之一。在本研究中,我们以时间和浓度依赖的方式,检测了戈米辛 J 在 MCF7 和 MDA-MB-231 乳腺癌细胞系和 MCF10A 正常细胞系中的抗癌活性。研究数据显示,戈米辛 J 对 MCF7 和 MDA-MB-231 癌细胞的细胞毒性作用明显强于 MCF10A 正常细胞。戈米辛 J 以相对较低(<10μg/ml)和较高(>30μg/ml)浓度分别抑制 MCF7 和 MDA-MB-231 细胞的增殖并降低其活力。研究数据还表明,戈米辛 J 诱导程序性坏死(necroptosis)和细胞凋亡。值得注意的是,戈米辛 J 主要诱导具有高抗药性的 MCF7 细胞发生坏死,而 MDA-MB-231 则表现出较低水平的坏死和更高水平的凋亡。这一数据表明,戈米辛 J 可能成为一种更有效的抗癌药物,尤其是针对抗凋亡性的恶性肿瘤细胞。在一项扩展研究中,戈米辛 J 对所有测试的 13 种不同类型的癌细胞系均表现出强烈的细胞毒性作用,表明其可能对广泛的不同类型的癌细胞有效。